Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis
NCT ID: NCT05787704
Last Updated: 2024-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2023-04-21
2024-05-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecological valid state. The investigators aim therefore to explore brain function during complex walking in MS (in comparison with people with Parkinson's disease and healthy controls) by investigating the effects of neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in people with MS (in comparison with people with Parkinson's disease and healthy adults).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
NCT03608527
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis
NCT04619953
Impact of Neuropsychological Disorders in Multiple Sclerosis
NCT04837365
Effects of Cerebellum or Supplementary Motor Area Functional Inactivation on Gait and Balance Control
NCT02976298
Cerebellar RTMS in Patients with Multiple Sclerosis
NCT06265922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiple Sclerosis
People with Multiple Sclerosis, 18 years or older
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with an MS diagnosis according to McDonald criteria
* with the ability to walk without a mobility device for ≥5 minutes continuously.
Exclusion Criteria
* MS relapse or change of disease-modifying treatment within the past eight weeks.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Franzén
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erika Franzén, PhD9
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Stockholm, Solna, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-03059
Identifier Type: OTHER
Identifier Source: secondary_id
4-1673/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.